Improved vaccination against Newcastle disease by an in ovo recombinant HVT-ND combined with an adjuvanted live vaccine at day-old

Vaccine

Volumn 28, Issue 3, 2010, Pages 823-833

  Rauw, Fabienne ^a   Gardin, Yannick ^b   Palya, Vilmos ^c   Anbari, Sofia ^a   Lemaire, Sophie ^a   Boschmans, Marc ^a   van den Berg, Thierry ^a   Lambrecht, Bénédicte ^a  

^a VETERINARY AND AGROCHEMICAL RESEARCH CENTRE   (Belgium)

^b CEVA SANTÉ ANIMALE   (France)

^c Ceva Phylaxia Veterinary Biologicals Co Ltd   (Hungary)

Author keywords

Chitosan; Immunity; Newcastle Disease Virus; Recombinant turkey herpesvirus; Vaccination

Indexed keywords

CEVAC VITAPEST; CHITOSAN; HERPES VACCINE; LIVE VACCINE; NEWCASTLE DISEASE VACCINE; RECOMBINANT HERPESVIRUS OF TURKEY NEWCASTLE DISEASE VACCINE; RECOMBINANT VACCINE; UNCLASSIFIED DRUG; VECTOMUNE; VIRUS ANTIBODY;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIBODY TITER; ARTICLE; BIRD DISEASE; CELLULAR IMMUNITY; CHICKEN; CONTROLLED STUDY; DRUG EFFICACY; DUODENUM; FUSION GENE; HERPES VIRUS; HUMORAL IMMUNITY; IMMUNE RESPONSE; NEWCASTLE DISEASE PARAMYXOVIRUS; NONHUMAN; PRIORITY JOURNAL; SPLEEN CELL; VACCINATION; VIRUS SHEDDING; VIRUS STRAIN;

ADJUVANTS, IMMUNOLOGIC; ADMINISTRATION, INTRANASAL; ANIMALS; ANTIBODIES, VIRAL; CHICKENS; CHITOSAN; CLOACA; GENETIC VECTORS; HERPESVIRUS 1, MELEAGRID; NEWCASTLE DISEASE; OVUM; SPLEEN; SURVIVAL ANALYSIS; T-LYMPHOCYTES; VACCINATION; VACCINES, ATTENUATED; VACCINES, SYNTHETIC; VIRAL FUSION PROTEINS; VIRAL VACCINES; VIRUS SHEDDING;

EID: 71349085608     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2009.10.049     Document Type: Article

References (58)

1. Bermudez A.J., and Stewart-Brown B. Disease prevention and diagnostic. In: Saif Y.M. (Ed). Disease of Poultry. 11th ed. (2003), Iowa State University Press, Iowa 17-55
2. Senne D.A., King D.J., and Kapczynski D.R. Control of Newcastle disease by vaccination. Dev Biol 119 (2004) 165-170
3. Van Boven M., Bouma A., Fabri T.H.F., Katsma E., Hartog L., and Koch G. Herd immunity to Newcastle disease virus in poultry by vaccination. Avian Pathol 37 1 (2008) 1-5
4. Kapczynski D.R., and King D.J. Protection of chickens against overt clinical disease and determination of viral shedding following vaccination with commercially available Newcastle disease virus vaccines upon challenge with highly virulent virus from the California 2002 exotic Newcastle disease outbreak. Vaccine 23 (2005) 3424-3433
5. Westbury H.A., Parsons G., and Allan W.H. Comparison of the immunogenicity of Newcastle disease virus strains V4, Hitchner B1 and La Sota in chickens. 2. Tests in chickens with maternal antibody to the virus. Aust Vet J 61 (1984) 10-13
6. Bell I.G., Nicholls P.J., Norman C., Cooper K., and Cross G.M. The serological responses of chickens to mass vaccination with a live V4 Newcastle disease virus vaccine in the field and the laboratory. 1. Meat chickens. Aust Vet J 68 3 (1991) 85-89
7. Czifra G., Meszaros J., Horváth E., Moving V., and Engstrom B.E. Detection of NDV-specific antibodies and the level of protection provided by a single vaccination in young chickens. Avian Pathol 27 6 (1998) 562-565
8. Beard C.W., and Brugh M. Immunity to Newcastle disease. Am J Vet Res 136 (1975) 509-512
9. Russell P.H., Dwivedi P.N., and Davison T.F. The effect of cyclosporin A and cyclophosphamide on the populations of B and T cells and virus in the Harderian gland of chickens vaccinated with the Hitchner B1 strain of Newcastle disease virus. Vet Immunol Immunopathol 60 (1997) 171-185
10. Takada A., and Kida H. Protective immune response of chickens against Newcastle disease, induced by the intranasal vaccination with inactivated virus. Vet Microbiol 50 (1996) 17-25
11. Rauw F., Gardin Y., Palya V., van Borm S., Gonze M., Lemaire S., et al. Humoral, cell-mediated and mucosal immunity induced by oculo-nasal vaccination of one-day-old SPF and conventional layer chicks with two different live Newcastle Disease vaccines. Vaccine 27 (2009) 3631-3642
12. Miller P.J., King D.J., Afonso C.L., and Suarez D.L. Antigenic differences among Newcastle disease virus strains of different genotypes used in vaccine formulation affect viral shedding after a virulent challenge. Vaccine 27 41 (2007) 7238-7246
13. Ahmad J.A., and Sharma J.M. Evaluation of a modified-live virus vaccine administrated in ovo to protect chickens against Newcastle disease. Am J Vet Res 53 11 (1992) 1999-2004
14. Mast J., Nanbru C., Decaesstecker M., Lambrecht B., Couvreur B., Meulemans G., et al. Vaccination of chickens embryos with escape mutants of La Sota Newcastle disease virus induces a protective immune response. Vaccine 24 (2006) 1756-1765
15. Morgan R.W., Gelb J.J., Schreurs C.S., Lutticken D., Rosenberger J.K., and Sondermeijer P.J.A. Protection of chickens from Newcastle and Marek' diseases with a recombinant herpesvirus of turkeys vaccine expressing the Newcastle disease virus fusion protein. Avian Dis 36 (1992) 858-870
16. Morgan R.W., Gelb J.J., Pope C.R., and Sondermeijer P.J.A. Efficacy in chickens of a herpesvirus of turkeys recombinant vaccine containing the fusion gene of Newcastle disease virus: onset of protection and effect of maternal antibodies. Avian Dis 37 4 (1993) 1032-1040
17. Sondermeijer P.J.A., Claessens J.A.J., Jenniskens P.E., Mockett A.P., Thijssen R.A., Willemse M.J., et al. Avian herpesvirus as a live viral vector for the expression of heterologous antigens. Vaccine 11 3 (1993) 349-358
18. Heckert R.A., Riva J., Cook S., McMillen J., and Schwartz R.D. Onset of protective immunity in chicks after vaccination with a recombinant herpesvirus of turkeys vaccine expressing Newcastle disease virus fusion and hemagglutinin-neuraminidase antigens. Avian Dis 40 4 (1996) 770-777
19. Reddy S.K., Sharma J.M., Ahmad J., Reddy D.N., McMillen J.K., Cook S.M., et al. Protective efficacy of a recombinant herpesvirus of turkeys as an in ovo vaccine against Newcastle and Marek's diseases in specific-pathogen-free chickens. Vaccine 14 6 (1996) 469-477
20. Boursnell M.E.G., Green P.F., Samson A.C.R., Campbell J.I., Deuter A., Peters R.W., et al. A recombinant fowlpox virus expressing the hemagglutinin-neuraminidase gene of Newcastle disease virus (NDV) protects chickens against challenge by NDV. Virology 178 (1990) 297-300
21. Taylor J., Edbauer C., Rey-Senelonge A., Bouquet J.F., Norton E., Goebel S., et al. Newcastle disease virus fusion protein expressed in a fowlpox virus recombinant confers protection in chickens. J Virol 64 (1990) 1441-1450
22. Iritani Y., Aoyama S., Takigami S., Hayashi Y., Ogawa R., Yanagida N., et al. Antibody response to Newcastle disease virus (NDV) of recombinant fowlpox virus (FPV) expressing a hemagglutinin-neuraminidase of NDV into chickens in the presence of antibody to NDV or FPV. Avian Dis 35 4 (1991) 659
23. Nagy E., Krell P.J., Dulac G.C., and Derbyshire J.B. Vaccination against Newcastle disease with a recombinant baculovirus hemagglutinin-neuraminidase subunit vaccine. Avian Dis 35 (1991) 585-590
24. McNillen J.K., Cochran M.D., Junker D.E., Reddy D.N., and Valencia D.M. The safe and effective use of fowlpox virus as vector for poultry vaccines. Dev Biol Stand 82 (1994) 137-145
25. Karaca K., Sharma J.M., Winslow B.J., Junker D.E., Reddy S., Cochran M., et al. Recombinant fowlpox viruses coexpressing chicken type I IFN and Newcastle disease virus HN and F genes: influence of IFN on protective efficacy and humoral responses of chickens following in ovo or post-hatch administration of recombinant viruses. Vaccine 16 16 (1998) 1496-1503
26. Sharma J.M., and Burmester B.R. Resistance to Marek's disease at hatching in chickens vaccinated as embryos with the turkey herpesvirus. Avian Dis 26 1 (1982) 134-149
27. Kamiya N., Niikura M., Ono M., Kai C., Matsuura Y., and Mikami T. Protective effect of individual glycoproteins of Newcastle disease virus expressed in insect cells: the fusion protein derived from an avirulent strain had lower protective efficacy. Virus Res 32 (1994) 373-379
28. Linghua Z., Xingshan T., and Fengzhen Z. Vaccination with Newcastle disease vaccine and CpG oligodeoxynucleotides induces specific immunity and protection against Newcastle disease virus in SPF chicken. Vet Immunol Immunopathol 115 (2007) 216-222
29. Zhang L., Zhang M., Li J., Cao T., Tian X., and Zhou F. Enhancement of mucosal immune responses by intranasal co-delivery of Newcastle disease vaccine plus CpG oligonucleotide in SPF chickens in vivo. Res Vet Sci 85 3 (2008) 495-502
30. Marcus P.I., van der Heide L., and Sekellick M.J. Interferon action on avian viruses. I. Oral administration of chicken interferon-α ameliorates Newcastle disease. J Interf Cytok Res 19 (1999) 881-885
31. Degen W.G.J., van Zuilekom H.I., Scholtes N.C., van Daal N., and Schijns V.E.C.J. Potentiation of humoral immune responses to vaccine antigens by recombinant chicken IL-18 (rChIL-18). Vaccine 23 (2005) 4212-4218
32. Rauw F, Gardin Y, Palya V, Anbari S, Gonze M, Lemaire S, et al. Improvement of cell-mediated immunity and protection against Newcastle Disease by the use of chitosan as adjuvant for live Newcastle Disease vaccine. Vet Immunol Immunopathol; in press.
33. Roy P., Venugopalan A.T., and Koteeswaran A. Efficacy of live adjuvanted mesogenic Newcastle disease vaccine in chickens. Vaccine 17 (1999) 2674-2676
34. Zhang X., Zhang X., and Yang Q. Effect of compound mucosal immune adjuvant on mucosal and systemic immune responses in chicken orally vaccinated with attenuated Newcastle-disease vaccine. Vaccine 25 (2007) 3254-3262
35. Meszaros J. Aerosol-vaccination against Newcastle disease. Deut Tierarztl Woch 98 (1991) 117-164
36. Meszaros J., Szemeredi M., and Tamasi G. Immunization of day-old chickens against Newcastle disease. Acta Vet Hung 40 (1992) 121-127
37. Czegledi A., Ujvari D., Somogyi E., Wehmann E., Werner O., and Lomniczi B. Third genome size category of avian paramyxovirus serotype 1 (Newcastle disease virus) and evolutionary implications. Virus Res 120 (2006) 36-48
38. Sato H., Oh-hira M., Ishida N., Imamura Y., Hattori S., and Kawakita M. Molecular cloning and nucleotide sequence of P, M and F genes of Newcastle disease virus avirulent strain D26. Virus Res 7 3 (1987) 241-255
39. Calderon N.L., Galindo-Muniz F., Ortiz M., Lomniczi B., Fehervari T., and Paasch L.H. Thrombocytopenia in Newcastle Disease: haematological evaluation and histological study of bone marrow. Acta Vet Hung 53 4 (2005) 507-513
40. Lambrecht B., Gonze M., Meulemans G., and van den Berg T. Assessment of the cell-mediated immune response in chickens by detection of chicken interferon-gamma in response to mitogen and recall Newcastle disease viral antigen stimulation. Avian Pathol 33 (2004) 343-350
41. Van Borm S., Steensels M., Ferreira H.L., Boschmans M., De Vrise J., Lambrecht B., et al. A universal avian endogenous real-time reverse transcriptase-polymerase chain reaction control and its application to avian influenza diagnosis and quantification. Avian Dis 51 (2007) 213-220
42. Palya V., Penzes Z., Horváth T., Kardi V., Dorsey Moore K., and Gardin Y. Comparative efficacy of several vaccination programmes including or not recombinant HVT-ND vaccine against challenge with Mexican Chimalhuacan NDV strain. 57th western poultry disease conference & XXXIII annual ANECA convention. Mexico (2008) 36-38
43. Heller E.D., and Schat K.A. Enhancement of natural killer cell activity by Marek's disease vaccines. Avian Pathol 16 1 (1987) 51-60
44. Sharma J.M., Lee L.F., and Wakenell P.S. Comparative viral, immunologic, and pathologic responses of chickens inoculated with herpesvirus of turkeys as embryos or at hatch. Am J Vet Res 45 8 (1982) 1619-1623
45. Tsukamoto K., Saito S., Saeki S., Sato T., Tanimura N., Isobe T., et al. Complete, long-lasting protection against lethal infectious bursal disease virus challenge by a single vaccination with an avian herpesvirus vector expressing VP2 antigens. J Virol 76 11 (2002) 5637-5645
46. Cambre J.F.R., Hein R.G., Dominguez V., and Aguilera A. The effect of using a HVT/ND+SB-1 recombinant vaccine on the reisolation of Newcastle disease virus Chimalhuacan strain. 57th western poultry disease conference & XXXIII annual ANECA convention. Mexico (2008) 35
47. Hein R.G., Rios J.F., Aguilera A., and Domhof J. Newcastle disease (ND) efficacy in broilers vaccinated at one day of age with the recombinant HVT/F(ND):innovac-ND-SB challenged with the Mexican vND virus isolate Chimalhuacan. 57th western poultry disease conference & XXXIII annual ANECA convention. Mexico (2008) 32-33
48. Johnston P.A., Liu H., O'Connell T., Phelps P., Bland M., Tyczkowki J., et al. Applications in in ovo technology. Poultry Sci 76 1 (1997) 165-178
49. Jochemsen P., and Jeurissen S.H.M. The localization and uptake of in ovo injection soluble and particulate substances in the chicken. Poultry Sci 81 (2002) 1811-1817
50. McNeela E.A., O'Connor D., Jabbal-Gill I., Illum L., Davis S.S., Pizza M., et al. A mucosal vaccine against diphtheria: formulation of cross reacting material (CRM197) of diphtheria toxin with chitosan enhances local and systemic antibody and Th2 responses following nasal delivery. Vaccine 19 (2001) 1188-1198
51. Ahmed R., and Gray D. Immunological memory and protective immunity: understanding their relation. Science 272 5258 (1996) 54-60
52. Butcher E.C., and Picker L.J. Lymphocyte homing and homeostasis. Science 272 (1996) 60-66
53. Meeusen E.N. Differential migration of Th1 and Th2 cells-implications for vaccine and infection studies. Vet Immunol Immunopathol 63 1-2 (1998) 157-166
54. Mora J.R., and von Andrian U.H. T-cell homing specificity and plasticity: new concepts and future challenges. Trends Immunol 27 5 (2006) 235-242
55. Agace W.W. T-cell recruitment to the intestinal mucosa. Trends Immunol 29 11 (2008) 514-522
56. Al-Garib S.O., Gielkens A.L.J., Gruys E., Hartog L., and Koch G. Immunoglobulin class distribution of systemic and mucosal antibody responses to Newcastle disease in chickens. Avian Dis 47 (2003) 32-40
57. Perozo F., Villegas P., Dolz R., Afonso C.L., and Purvis L.B. The VG/GA strain of Newcastle disease virus: mucosal immunity, protection against lethal challenge and molecular analysis. Avian Pathol 37 3 (2008) 237-245
58. Zoth S.C., Gomez E., Carrillo E., and Berinstein A. Locally produced mucosal IgG in chickens immunized with conventional vaccines for Newcastle disease virus. Braz J Med Biol Res 41 (2008) 318-323